Drug abuse in pregnancy and neonatal morbidity;Drogas en el embarazo y morbilidad neonatal

Anales de Pediatria

Volumn 58, Issue 6, 2003, Pages 519-522

  Echeverria Lecuona J ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ABUSE; DRUG UTILIZATION; DRUG WITHDRAWAL; EDITORIAL; FETUS (ANATOMY); HUMAN; NEWBORN MORBIDITY; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; WITHDRAWAL SYNDROME;

EID: 0038167221     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13048097     Document Type: Editorial

References (24)

1. Kelly JJ, Davis PG, Henschke PN. The drug epidemic: Effects on newborn infants and health resource consumption at a tertiary perinatal centre. J Paediatr Child Health 2000;36:262-4.
2. Moe V, Slinning K. Prenatal drug exposure and the conceptualization of long-term effects. Scand J Psychol 2002;43:41-7.
3. Smith LM, Chang L, Yonekura ML, Gilbride K, Kuo J, Poland RE, et al. Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. Pediatrics 2001;107:227-31.
4. Eyler FD, Behnke M, Garvan CW, Woods NS, Wobie K, Colon M. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicology Teratology 2001; 23:399-411.
5. Leckman EB, Mayes LC, Hodgins HS. Perceptions and attitudes toward prenatal cocaine exposure in young children. Child Psychiatry Human Development 2001;31:313-2.
6. Accornero VH, Morrow CE, Bandstra ES, Johnson AL, Anthony JC. Behavioral outcome of preschoolers exposed prenatally to cocaine: Role of maternal behavioral health. J Pediatr Psychol 2002;27:259-69.
7. Mitchell ES, Keller RW Jr, Snyder-Keller A. Immediate-early gene expression in concurrent prenatal ethanol- and/or cocaine-exposed rat pups: Intrauterine differences in cocaine levels and Fos expression. Brain Research. Developmental Brain Research 2002;133:141-9.
8. Lux AL, Henderson AJ, Pocock SJ, The ALSPAC study Team. Wheeze associated with prenatal tobacco smoke exposure: A prospective, longitudinal study. Arch Dis Child 2000;83: 307-12.
9. Cano Fernández J, Zabaleta Camino C, De la Torre Montes de Neira E, Yep Chulen GA, Melendi Crespo JM, Sánchez Bayle M. Tabaquismo pasivo prenatal y postnatal y bronquiolitis. An Pediatr 2003;58:115-20.
10. Butz AM, Pulsifer M, Marano N, Belcher H, Lears MK, Royall R. Effectiveness of a home intervention for perceived child behavioral problems and parenting stress in children with in utero drug exposure. Arch Pediatr Adol Med 2001;155:1029-37.
11. Thadani PV. The intersection of stress, drug abuse and development. Psychoneuroendocrinology 2002;27:221-30.
12. Finnegan LP, Connaughton JF, Kron RE, Emich JP. Neonatal abstinence syndrome: Assessment and management. Addict Dis 1975;2:141-58.
13. www.cs.nsw.gov.au/rpa/neonatal/htlm/newport/nas/htm
14. White-Traut R, Studer T, Meleedy-Rey P, Murray P, Labovsky S, Kahn J. Pulse rate and behavioral state correlates after auditory, tactile, visual, and vestibular intervention in drug-exposed neonates. J Perinatol 2002;22:291-9.
15. O'Brien CM, Jeffery HE. Sleep deprivation, disorganization and fragmentation during opiate withdrawal in newborns. J Paediatr Child Health 2002;38:66-71.
16. Floch-Tudal C, Simonpoli AM, Montamat S, Couettoux MP, Crenn-Hebert C, Lejeune C. Neonatal withdrawal syndrome in twins born to a mother on methadone substitution. Ann Med Intern 2000;151(Suppl B):30-3.
17. D'Apolito KC, McRorie TI. Pharmacologic management of neonatal abstinence syndrome. J Perinat Neonat Nursing 1996;9: 70-80.
18. Theis JG, Selby P, Ikizler Y, Koren G. Current management of the neonatal abstinence syndrome: A critical analysis of the evidence. Biol Neonate 1997;71:345-56.
19. Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr 2002;140: 561-4.
20. Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatol 1996;74:204-7.
21. Ziegler M, Poustka F, Von Loewenich V, Englert E. Postpartum risk factors in the development of children born to opiate-addicted mothers; comparison between mothers with and without methadone substitution. Nervenarzt 2000;71:730-6.
22. Gomart E. Methadone: Six effects in search of a substance. Soc Stud Science 2002;32:93-135.
23. Ballard JL. Treatment of neonatal abstinence syndrome with breast milk containing methadone. J Perinat & Neonat Nurs 2002;15:76-85.
24. Oei J, Feller JM, Lui K. Coordinated outpatient care of the narcotic-dependent infant. J Paediatr Child Health 2001;37:266-70.